Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Clinical Nuclear Medicine|April 15, 2022
Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy Are More Prevalent in Women Than in MenNoémie S Minczeles, Wouter W de Herder, Mark W Konijnenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2021
Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo SurvivalGiulia Tamborino, Julie Nonnekens, Marijke De Saint-Hubert, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitroAstrid Capello, Eric P Krenning, Wout A P Breeman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 20, 2009
Intra-patient reproducibility of myocardial SPECT imaging with 201TlBarbra E Backus, Frederik A Verburg, R Leo Romijn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2023
Urinary excretion kinetics of [177Lu]Lu-PSMA-617Maarten de Bakker, Noa Dominicus, Antoi Meeuwis, et al.
EJNMMI Physics|September 26, 2024
Accuracy of holmium-166 SPECT/CT quantification over a large range of activitiesLovisa E L Westlund Gotby, Daphne Lobeek, Joey Roosen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2011
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?Stephan Walrand, Glenn D Flux, Mark W Konijnenberg, et al.
EJNMMI Physics|April 3, 2024
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CTDagmar Grob, Bastiaan M Privé, Constantijn H J Muselaers, et al.
Nuclear Medicine Communications|April 30, 2010
Effect of time and exercise on the clearance rate of (201)Tl in normal and ischemic myocardiumBarbra E Backus, Rachel E L Hezemans, Frederik A Verburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide TherapyGiulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, et al.
Pageof 7